Inventor · disambiguated record
Frank Mercurio
Also filed as: MERCURIO FRANK · MERCURIO FRANK M
48 granted patents·15 pending applications·253 citations·filing 1987–2023
98Inventor score
Top patents by PatentIndex Score
63 records- 0195US10144745B2Chimeric compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2017·Granted Dec 4, 2018·15 cites·18 claims
- 0295US10040804B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2017·Granted Aug 7, 2018·17 cites·30 claims
- 0393US9938302B2Chimeric compounds targeting proteins, compositions, methods, and uses thereofBIO THERYX INC·Filed 2017·Granted Apr 10, 2018·21 cites·26 claims
- 0492US10889593B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2019·Granted Jan 12, 2021·4 cites·27 claims
- 0592US10336771B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Granted Jul 2, 2019·8 cites·24 claims
- 0689US10513515B2Ether compounds and uses thereofBIOTHERYX INC·Filed 2018·Granted Dec 24, 2019·4 cites·28 claims
- 0788US10406165B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Granted Sep 10, 2019·6 cites·25 claims
- 0887US10669260B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2017·Granted Jun 2, 2020·3 cites·15 claims
- 0986US10905684B2Aminoamide compoundsBIOTHERYX INC·Filed 2019·Granted Feb 2, 2021·2 cites·29 claims
- 1083US11236105B2Bicyclic compounds and methods of useBIOTHERYX INC·Filed 2020·Granted Feb 1, 2022·1 cites·22 claims
- 1183US6576437B2Stimulus-inducible protein kinase complex and methods of use thereforSIGNAL PHARM INC·Filed 2001·Granted Jun 10, 2003·13 cites·10 claims
- 1282US9822098B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2016·Granted Nov 21, 2017·3 cites·22 claims
- 1380US10570147B2Bicyclic compounds and methods of useBIOTHERYX INC·Filed 2018·Granted Feb 25, 2020·2 cites·30 claims
- 1480US6656713B2Compounds and methods for modulating activation of NF-κBSIGNAL PHARM INC·Filed 2001·Granted Dec 2, 2003·14 cites·7 claims
- 1578US10844039B2Substituted isoindolinonesBIOTHERYX INC·Filed 2019·Granted Nov 24, 2020·1 cites·36 claims
- 1678US8334307B2Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseasesMERCURIO FRANK·Filed 2011·Granted Dec 18, 2012·3 cites·23 claims
- 1775US7414120B2Compounds and methods for modulating activation of NF-κBSIGNAL PHARMACEUTICALS·Filed 2007·Granted Aug 19, 2008·2 cites·7 claims
- 1874US11345714B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2021·Granted May 31, 2022·0 cites·32 claims
- 1974US9527815B2Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseasesBIOTHERYX INC·Filed 2015·Granted Dec 27, 2016·2 cites·32 claims
- 2074US7285654B2Stimulus-inducible protein kinase complex and methods of use thereforSIGNAL PHARMACEUTICALS·Filed 2003·Granted Oct 23, 2007·4 cites·18 claims
- 2174US7037936B2Compounds useful for the treatment of cancer, compositions thereof and methods therewithSIGNAL PHARM LLC·Filed 2003·Granted May 2, 2006·8 cites·2 claims
- 2272US6258579B1Stimulus-inducible protein kinase complex and methods of use thereforSIGNAL PHARM INC·Filed 1997·Granted Jul 10, 2001·28 cites·4 claims
- 2372US5932425ACompositions and methods for modulating cellular NF-κB activationSIGNAL PHARM INC·Filed 1997·Granted Aug 3, 1999·35 cites·7 claims
- 2470US5972674AStimulus-inducible protein kinase complex and methods of use thereforSIGNAL PHARM INC·Filed 1996·Granted Oct 26, 1999·18 cites·2 claims
- 2569US4937185ADetection of circulating antibodies to a cancer marker proteinUNIV OHIO STATE RES FOUND·Filed 1987·Granted Jun 26, 1990·29 cites·6 claims
- 2667US2022298172A1Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 2766US2022153751A1Bifunctional compoundsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 2865US10927104B2Ether compounds and uses thereofBIOTHERYX INC·Filed 2019·Granted Feb 23, 2021·0 cites·26 claims
- 2964US11400084B2Aminoamide compoundsBIOTHERYX INC·Filed 2021·Granted Aug 2, 2022·0 cites·21 claims
- 3064US11352338B2Substituted isoindolinonesBIOTHERYX INC·Filed 2020·Granted Jun 7, 2022·0 cites·22 claims
- 3164US8119421B2Methods to identify compounds useful for the treatment of proliferative and differentiative disordersPAGANO MICHELE·Filed 2008·Granted Feb 21, 2012·0 cites·13 claims
- 3264US7186503B2Compounds and methods for modulating activation of NF-κBSIGNAL PHARM LLC·Filed 2003·Granted Mar 6, 2007·2 cites·4 claims
- 3364US2022088025A1Fused thiophene compoundsBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 3463US11191769B2Fused thiophene compoundsBIOTHERYX INC·Filed 2019·Granted Dec 7, 2021·0 cites·39 claims
- 3562US12220399B2Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseasesNEUROTHERYX CANADA LTD·Filed 2022·Granted Feb 11, 2025·0 cites·17 claims
- 3662US11236103B2Bifunctional compoundsBIOTHERYX INC·Filed 2019·Granted Feb 1, 2022·0 cites·33 claims
- 3762US10562917B2Chimeric compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Granted Feb 18, 2020·0 cites·22 claims
- 3861US9546131B2Substituted biaryl alkyl amidesBIOTHERYX INC·Filed 2014·Granted Jan 17, 2017·0 cites·27 claims
- 3961US9273005B2Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseasesBIOTHERYX INC·Filed 2012·Granted Mar 1, 2016·0 cites·17 claims
- 4061US7759476B2Double-stranded RNAS directed to IKK-2SIGNAL PHARMACEUTICALS·Filed 2007·Granted Jul 20, 2010·0 cites·11 claims
- 4161US2019276474A1Chimeric compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Application pending·0 cites
- 4258US8822527B2Substituted biaryl alkyl amidesBIOTHERYX INC·Filed 2012·Granted Sep 2, 2014·0 cites·38 claims
- 4358US2015044228A1Methods to identify compounds useful for the treatment of proliferative and differentiative disordersUNIV NEW YORK·Filed 2014·Application pending·0 cites
- 4457US10106491B2Substituted biaryl alkyl amidesBIOTHERYX INC·Filed 2016·Granted Oct 23, 2018·0 cites·17 claims
- 4557US2024158370A1CK1 alpha AND DUAL CK1 alpha / GSPT1 DEGRADING COMPOUNDSINNOVO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4656US10857155B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2019·Granted Dec 8, 2020·0 cites·9 claims
- 4756US8263326B2Compounds and methods for modulating activation of NF-κBMANNING ANTHONY M·Filed 2008·Granted Sep 11, 2012·0 cites·5 claims
- 4856US2024124418A1Pde4 degraders, pharmaceutical compositions, and therapeutic applicationsBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 4954US11433047B2Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseasesBIOTHERYX INC·Filed 2016·Granted Sep 6, 2022·0 cites·35 claims
- 5053US2012164656A1Methods To Identify Compounds Useful For The Treatment Of Proliferative And Differentiative DisordersPAGANO MICHELE·Filed 2011·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Frank Mercurio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →